The first drug for the treatment of Alzheimer’s disease is approved in the United States
The US Food and Drug Administration (FDA) has authorized the use of Leqembi, a drug designed to slow the progression of Alzheimer's disease. It is noted that this is the only drug of its kind approved by the FDA.
Leqembi uses antibodies…